Azithromycin Resistance in Shiga Toxin-Producing Escherichia coli in France between 2004 and 2020 and Detection of


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
15 02 2022
Historique:
pubmed: 7 12 2021
medline: 23 3 2022
entrez: 6 12 2021
Statut: ppublish

Résumé

We described and characterized Shiga-toxin-producing Escherichia coli (STEC) strains with high levels of resistance to azithromycin isolated in France between 2004 and 2020. Nine of 1,715 (0.52%) STEC strains were resistant to azithromycin, with an increase since 2017. One isolate carried a plasmid-borne

Identifiants

pubmed: 34871091
doi: 10.1128/AAC.01949-21
pmc: PMC8846429
doi:

Substances chimiques

Escherichia coli Proteins 0
Azithromycin 83905-01-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0194921

Références

Arch Pediatr Adolesc Med. 2002 Sep;156(9):893-900
pubmed: 12197796
Pediatr Infect Dis J. 2018 Jan;37(1):52-58
pubmed: 28746259
Foodborne Pathog Dis. 2013 Sep;10(9):805-12
pubmed: 23808851
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Methods Mol Biol. 2020;2075:285-294
pubmed: 31584170
BMC Genomics. 2008 Feb 08;9:75
pubmed: 18261238
Antimicrob Agents Chemother. 2012 Jun;56(6):3277-82
pubmed: 22391549
Sci Rep. 2019 Apr 15;9(1):6089
pubmed: 30988366
Toxins (Basel). 2020 Jan 21;12(2):
pubmed: 31973203
J Antimicrob Chemother. 2016 May;71(5):1183-7
pubmed: 26832755
Euro Surveill. 2019 Mar;24(13):
pubmed: 30940315
Antimicrob Agents Chemother. 2000 Aug;44(8):2205-6
pubmed: 10898704
Crit Rev Microbiol. 2017 Feb;43(1):1-30
pubmed: 27786586
Antimicrob Agents Chemother. 2002 Nov;46(11):3478-83
pubmed: 12384353
Antimicrob Agents Chemother. 2007 Aug;51(8):2837-41
pubmed: 17526759
Int J Epidemiol. 2014 Aug;43(4):1105-13
pubmed: 24659584
J Antimicrob Chemother. 2020 Mar 1;75(3):537-542
pubmed: 31773130
J Antimicrob Chemother. 2017 Jan;72(1):145-152
pubmed: 27678285
J Infect. 2019 Aug;79(2):75-94
pubmed: 31150744
Clin Microbiol Infect. 2013 Feb;19(2):141-60
pubmed: 22117544
J Glob Antimicrob Resist. 2017 Sep;10:47-53
pubmed: 28689921
Microbes Environ. 2012;27(3):263-72
pubmed: 22446310
Nat Commun. 2018 Jan 9;9(1):112
pubmed: 29317655
JAMA. 2002 Aug 28;288(8):996-1001
pubmed: 12190370
JAMA. 2012 Mar 14;307(10):1046-52
pubmed: 22416100
N Engl J Med. 2013 Apr 11;368(15):1461-2
pubmed: 23574140

Auteurs

Etienne Bizot (E)

Service de Microbiologie, Centre National de Référence Escherichia coli, Hôpital Robert-Debré, Paris, France.

Aurélie Cointe (A)

Service de Microbiologie, Centre National de Référence Escherichia coli, Hôpital Robert-Debré, Paris, France.
Université de Paris, IAME, INSERM, Paris, France.

Philippe Bidet (P)

Service de Microbiologie, Centre National de Référence Escherichia coli, Hôpital Robert-Debré, Paris, France.
Université de Paris, IAME, INSERM, Paris, France.

Patricia Mariani-Kurkdjian (P)

Service de Microbiologie, Centre National de Référence Escherichia coli, Hôpital Robert-Debré, Paris, France.

Claire Amaris Hobson (CA)

Université de Paris, IAME, INSERM, Paris, France.

Céline Courroux (C)

Service de Microbiologie, Centre National de Référence Escherichia coli, Hôpital Robert-Debré, Paris, France.

Sandrine Liguori (S)

Service de Microbiologie, Centre National de Référence Escherichia coli, Hôpital Robert-Debré, Paris, France.

Antoine Bridier-Nahmias (A)

Université de Paris, IAME, INSERM, Paris, France.

Mélanie Magnan (M)

Université de Paris, IAME, INSERM, Paris, France.

Manel Merimèche (M)

Université de Paris, IAME, INSERM, Paris, France.
Service de Microbiologie, AP-HP, Hôpital Saint-Louis, Paris, France.

François Caméléna (F)

Université de Paris, IAME, INSERM, Paris, France.
Service de Microbiologie, AP-HP, Hôpital Saint-Louis, Paris, France.

Béatrice Berçot (B)

Université de Paris, IAME, INSERM, Paris, France.
Service de Microbiologie, AP-HP, Hôpital Saint-Louis, Paris, France.

François-Xavier Weill (FX)

Institut Pasteurgrid.428999.7, Unité des bactéries pathogènes entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Paris, France.

Sophie Lefèvre (S)

Institut Pasteurgrid.428999.7, Unité des bactéries pathogènes entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Paris, France.

Stéphane Bonacorsi (S)

Service de Microbiologie, Centre National de Référence Escherichia coli, Hôpital Robert-Debré, Paris, France.
Université de Paris, IAME, INSERM, Paris, France.

André Birgy (A)

Service de Microbiologie, Centre National de Référence Escherichia coli, Hôpital Robert-Debré, Paris, France.
Université de Paris, IAME, INSERM, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH